-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CpFPVEQVkIisAuLdagetnvPg0PDsmUDX/0uJDG0s62z/kgWbsLrA+POl/WRxw9R2 7P9V/GRYRMiJufXSVBZv5w== 0001209191-09-053312.txt : 20091117 0001209191-09-053312.hdr.sgml : 20091117 20091117191658 ACCESSION NUMBER: 0001209191-09-053312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091116 FILED AS OF DATE: 20091117 DATE AS OF CHANGE: 20091117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Popovits Kimberly J CENTRAL INDEX KEY: 0001333482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 091191773 MAIL ADDRESS: STREET 1: 675 ALMANOR AVENUE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2009-11-16 0 0001131324 GENOMIC HEALTH INC GHDX 0001333482 Popovits Kimberly J 301 PENOBSCOT DRIVE REDWOOD CITY CA 94403 1 1 0 0 President and CEO Common Stock 2009-11-16 4 S 0 5000 19.2601 D 333506 D Common Stock 2009-11-17 4 S 0 15000 19.1937 D 318506 D This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 9, 2009. Represents weighted average sale price. Actual sale prices ranged from $19.05 to $19.47. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 12, 2009. Represents weighted average sale price. Actual sale prices ranged from $19.03 to $19.48. G. Bradley Cole, Attorney-in-Fact 2009-11-17 -----END PRIVACY-ENHANCED MESSAGE-----